Skip to content
Trial Eligibility
Menu

Effects of Neuromodulation in Laryngeal Dystonia

NCT05095740

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Laryngeal dystonia (LD) causes excessive vocal fold abduction (opening) or adduction (closing) leading to decreased voice quality, job prospects, self-worth and quality of life. Individuals with LD often experience episodic breathy voice, decreased ability to sustain vocal fold vibration, frequent pitch breaks and in some cases, vocal tremor.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Laryngeal Dystonia
  • Focal Dystonia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
21 to 85 years
Sex
All
Healthy volunteers
Accepted
Sponsor
MGH Institute of Health Professions
Last updated on ClinicalTrials.gov
February 20, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Teresa J Kimberley · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.